Because of the animal data linking GLP-1 receptor agonists to C-cell tumours, patients with a personal or family history of MTC should discuss the potential risks and benefits of Wegovy with their specialist
Conclusion Our study reveals that the activation of NLRP3 inflammasome caused by mitophagy dysfunction plays an important role in cardiac hypertrophy induced by pressure overload, and semaglutide ameliorates the cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome
You may have grounds for a claim if you were prescribed Ozempic or Wegovy (or another GLP-1 drug such as Rybelsus, Mounjaro, or Zepbound) and were subsequently diagnosed with one or more of the following: gastroparesis or chronic delayed gastric emptying
Any one of those seven, if cleared, would push the market past the third-generic threshold Larsen described
In addition, certain plaintiffs allege that they suffer from both the gastrointestinal damages alleged in MDL No
